An exciting new discovery for the treatment of Alzheimer's disease!

UBC, the University of British Columbia, reports,

A drug commonly used to treat cancer can restore memory and cognitive function in mice that display symptoms of Alzheimer's disease, new UBC research has found.

The drug, Axitinib, inhibits the growth of new blood vessels in the brain—a feature shared by both cancer tumors and Alzheimer's disease, but this hallmark represents a new target for Alzheimer's therapies.

Potential Alzheimer's treatments have shown promise in animal models before, but failed in clinical trials. Typically, these strategies target a protein called tau or a protein fragment known as beta-amyloid, but the UBC researchers chose a different approach. They left the traditional targets alone and instead focused on curbing angiogenesis, the growth of new blood vessels.

Read more here: https://medicalxpress.com/news/2021-10-cancer-chemotherapy-drug-reverses-alzheimer.html Thanks to Glenn Reynolds